Skip to content
healthcare.dev

Fexofenadine Hydrochloride

NDC 62207-765, Fexofenadine Hydrochloride, tablet, from Granules India Ltd.

Product NDC
62207-765
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211075
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-765 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEXOFENADINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
62207-765-49622070765491000 TABLET in 1 BOTTLE (62207-765-49)
62207-765-51622070765511 BOTTLE in 1 CARTON (62207-765-51) / 10 TABLET in 1 BOTTLE
62207-765-60622070765608 BLISTER PACK in 1 CARTON (62207-765-60) / 9 TABLET in 1 BLISTER PACK
62207-765-88622070765885 POUCH in 1 BOX (62207-765-88) / 10000 TABLET in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-765 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-765 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-765. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.